Metis Therapeutics Launches With $86 Million Series A Financing To Transform Drug Discovery And Delivery With Machine Learning And Artificial Intelligence
Metis Therapeutics Launches With $86 Million Series A Financing To Transform Drug Discovery And Delivery With Machine Learning And Artificial Intelligence
12/07/21, 11:00 AM
Location
cambridgeMoney raised
$86 million
Round Type
series a
METiS Therapeutics debuts today with $86 million Series A financing to harness artificial intelligence (AI) and machine learning to redefine drug discovery and delivery and develop optimal therapies for patients with serious diseases. PICC PE and China Life led the financing and were joined by Sequoia Capital China, Lightspeed, 5Y Capital, FreeS Fund and CMBI Zhaoxin Wuji Fund. The financing will be used to advance the company’s pipeline of novel assets with high therapeutic potential and the continued development of its AI-driven drug discovery and delivery platform.
Company Info
Location
cambridge, maryland, united states
Additional Info
METiS Therapeutics is a biotechnology company that aims to drive best-in-class therapies in a wide range of disease areas by integrating drug discovery and delivery with AI, machine learning, and quantum simulation. To learn more, visitwww.metistx.com/.